Prevalence and predictors of medication non-adherence among Chinese patients with first-episode psychosis

被引:18
|
作者
Hui, Christy Lai-Ming [1 ]
Poon, Venessa Wing-Yan [1 ]
Kwok, Vivian Shuk-Kuen [1 ]
Chang, Wing-Chung [1 ]
Chan, Sherry Kit-Wa [1 ]
Lee, Edwin Ho-Ming [1 ]
Chen, Eric Yu-Hai [1 ,2 ]
机构
[1] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China
关键词
Schizophrenia; Compliance; Adherence; Antipsychotics; Predictors; 1ST EPISODE PSYCHOSIS; OF-THE-LITERATURE; SCHIZOAFFECTIVE DISORDER; SCHIZOPHRENIC-PATIENTS; TREATMENT ADHERENCE; RISK-FACTORS; HONG-KONG; ANTIPSYCHOTICS; INTERVENTION; RELAPSE;
D O I
10.1016/j.psychres.2015.04.047
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Medication non-adherence is one of the major obstacles to recovery in first-episode psychosis (FEP). This study aimed to identify the predictors and rates of medication non-adherence in the first and second year after the start of treatment (baseline) in urban Chinese FEP patients. Relevant information on medication non-adherence and potential baseline predictors, including demographic variables, clinical measures, violence/suicide attempts, stressful life experiences, intervention received, and follow-up attendance, were collected from case records of 1400 FEP patients in Hong Kong. The non-adherence rate was 162% in year 1 and 15.4% in year 2. Regression analyses revealed the predictors for non-adherence in year 1 were no hospitalization at baseline, non-schizophrenia diagnosis, and more years of education. Predictors of non-adherence in year 2 included acute/subacute onset and older age of onset. Predictors common in both years were defaulting from psychiatric follow-up during baseline, standard psychiatric care (no early intervention), and lower positive symptoms severity at baseline. In assessing non-adherence risk and for planning phase-specific early interventions for FEP, particularly in a Chinese context, healthcare professionals should consider the common and specific predictors for non-adherence identified in the first and second years of treatment and should not overlook patients with less clinically severe symptoms. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:680 / 687
页数:8
相关论文
共 50 条
  • [21] Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
    Demjaha, A.
    Lappin, J. M.
    Stahl, D.
    Patel, M. X.
    MacCabe, J. H.
    Howes, O. D.
    Heslin, M.
    Reininghaus, U. A.
    Donoghue, K.
    Lomas, B.
    Charalambides, M.
    Onyejiaka, A.
    Fearon, P.
    Jones, P.
    Doody, G.
    Morgan, C.
    Dazzan, P.
    Murray, R. M.
    PSYCHOLOGICAL MEDICINE, 2017, 47 (11) : 1981 - 1989
  • [22] Sexual dysfunction in Chinese patients with first-episode psychosis: prevalence, clinical correlates and functioning
    Hui, Christy L. M.
    Lee, Edwin H. M.
    Chang, W. C.
    Chan, Sherry K. W.
    Li, Y. K.
    Lee, Jenny T. M.
    Chen, Eric Y. H.
    SCHIZOPHRENIA RESEARCH, 2013, 148 (1-3) : 181 - 182
  • [23] Indicators of medication compliance in first-episode psychosis
    Kampman, O
    Laippala, P
    Väänänen, J
    Koivisto, E
    Kiviniemi, P
    Kilkku, N
    Lehtinen, K
    NORDIC JOURNAL OF PSYCHIATRY, 2001, 55 (02) : 95 - 95
  • [24] Indicators of medication compliance in first-episode psychosis
    Kampman, O
    Laippala, P
    Väänanen, J
    Koivisto, E
    Kiviniemi, P
    Kilkku, N
    Lehtinen, K
    PSYCHIATRY RESEARCH, 2002, 110 (01) : 39 - 48
  • [25] Rate and predictors of service disengagement in patients with first-episode psychosis
    Verma, Swapna
    Zheng, Shushan
    Poon, Lye Yin
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 108 - 108
  • [26] Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis
    Pauselli, Luca
    Birnbaum, Michael L.
    Vazquez Jaime, Beatriz Paulina
    Paolini, Enrico
    Kelley, Mary E.
    Broussard, Beth
    Compton, Michael T.
    SCHIZOPHRENIA RESEARCH, 2018, 197 : 544 - 549
  • [27] Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis
    Arranz, B.
    San, L.
    Ramirez, N.
    Duenas, R. M.
    Perez, V.
    Salavert, J.
    Corripio, I.
    Alvarez, E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 119 (01) : 71 - 77
  • [28] Medication adherence of individuals with a first episode of psychosis
    Coldham, EL
    Addington, J
    Addington, D
    ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 (04) : 286 - 290
  • [29] Psychosis relapse, medication non-adherence, and cannabis
    Engh, John A.
    Bramness, Jorgen G.
    LANCET PSYCHIATRY, 2017, 4 (08): : 577 - 579
  • [30] THE PREVALENCE OF AUTOIMMUNE ENCEPHALITIS IN PATIENTS PRESENTING WITH FIRST-EPISODE PSYCHOSIS
    Scott, J. G.
    Gillis, D.
    Hargovan, H.
    Gundarpi, N.
    Ryan, A.
    Prain, K.
    Newman, M.
    Wong R, R.
    Parry, P.
    Blum, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 128 - 128